dantrolene is well established in the treatment of patients with muscle spasticity where it generally improves at least some of the components of spasticity ( i.e . hyper/hypotonia , clonus , muscle cramps and spasms , resistance to stretch and flexor reflexes , articular movement , neurological and motor functions and urinary control ) .
C0010976
dantrolene
C0026838
spasticity